Response to brentuximab vedotin versus physician's choice by CD30 expression and large cell transformation status in patients with mycosis fungoides: An ALCANZA sub-analysis

Youn H. Kim, H. Miles Prince, Sean Whittaker, Steven M. Horwitz, Madeleine Duvic, Oliver Bechter, Jose A. Sanches, Rudolf Stadler, Julia Scarisbrick, Pietro Quaglino, Pier Luigi Zinzani, Pascal Wolter, Herbert Eradat, Lauren C. Pinter-Brown, Pablo L. Ortiz-Romero, Oleg E. Akilov, Judith Trotman, Kerry Taylor, Michael Weichenthal, Jan WalewskiDavid Fisher, Marise McNeeley, Alejandro A. Gru, Lisa Brown, M. Corinna Palanca-Wessels, Julie Lisano, Matthew Onsum, Veronica Bunn, Meredith Little, William L. Trepicchio, Reinhard Dummer

Research output: Contribution to journal › Article › peer-review

28 Scopus citations

Fingerprint

Dive into the research topics of 'Response to brentuximab vedotin versus physician's choice by CD30 expression and large cell transformation status in patients with mycosis fungoides: An ALCANZA sub-analysis'. Together they form a unique fingerprint.

Medicine & Life Sciences